The revised 2024 McDonald criteria can solve the misdiagnosis problem in multiple sclerosis: No

Abstract

Get full access to this article

View all access options for this article.

References

Kalincik

Diouf

Sharmin

, et al. Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years. Neurology 2021; 96(5):e783–e797, https://www.neurology.org/doi/abs/10.1212/WNL.0000000000011242

Cerqueira

Compston

DAS

Geraldes

, et al. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry 2018; 89(8): 844–850, https://jnnp.bmj.com/content/89/8/844

Lazzarotto

Hamzaoui

Tonietto

, et al. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis. Brain 2024; 147(4): 1331–1343.

Calabrese

Gasperini

Tortorella

, et al. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study. Neurology 2019; 92(22): E2527–E2537, https://pubmed.ncbi.nlm.nih.gov/31043476/

Yamout

Khoury

Ayyoubi

, et al. Alternative diagnoses in patients referred to specialized centers for suspected MS. Mult Scler Relat Disord 2017; 18: 85–89, https://pubmed.ncbi.nlm.nih.gov/29141828/

Wang

Bou Rjeily

Koshorek

, et al. Clinical and radiologic characteristics associated with multiple sclerosis misdiagnosis at a tertiary referral center in the United States. Mult Scler 2023; 29(11–12): 1428–1436, https://pubmed.ncbi.nlm.nih.gov/37698023/

Gaitán

Sanchez

Farez

, et al. The frequency and characteristics of multiple sclerosis misdiagnosis in Latin America: A referral center study in Buenos Aires, Argentina. Mult Scler 2022; 28(9): 1373–1381, https://pubmed.ncbi.nlm.nih.gov/34971521/

Kaisey

Solomon

Luu

, et al. Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Mult Scler Relat Disord 2019; 30: 51–56, https://pubmed.ncbi.nlm.nih.gov/30738280/

Sinnecker

Clarke

Meier

, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 2019; 76(12): 1446–1456, https://jamanetwork.com/journals/jamaneurology/fullarticle/2748071

10.

Cagol

Cortese

Barakovic

et al. MAGNIMS study group. Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis. JAMA Neurol 2024; 81: 143–153. https://pubmed.ncbi.nlm.nih.gov/38079177/